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Abstract
Background:  Mycobacterium tuberculosis infection is an ongoing public health problem in
Taiwan. The National Tuberculosis Registry Campaign, a case management system, was
implemented in 1997. This study examined this monitoring system to identify and characterize
delayed treatment of TB patients.
Methods: Records of all tuberculosis cases treated in Taiwan from 2002 through 2005 were
obtained from the National Tuberculosis Registry Campaign. Initiation of treatment more than 7
days after diagnosis was considered a long treatment delay.
Results: The study included 31,937 patients. The mean day of delayed treatment was 3.6 days.
Most patients were treated immediately after diagnosis. The relationship between number of TB
patients and days of delayed treatment after diagnosis exhibited a Power-law distribution. The long
tail of the power-law distribution indicated that an extreme number occur cannot be neglected.
Tuberculosis patients treated after an unusually long delay require close observation and follow up.
Conclusion: This study found that TB control is generally acceptabl in Taiwan; however, delayed
treatment increases the risk of transmission. Improving the protocol for managing confirmed TB
cases can minimize disease transmission.
Background
Mycobacterium tuberculosis infection has long been a
public health problem in Taiwan. The annual incidence of
tuberculosis in Taiwan was 71.1/100,000 and 74.6/
100,000 in 1997 and 2002, respectively [1]. In aboriginal
mountainous areas, the reported incidence is even higher:
243.6/100,000 in 1997. In a geographic analysis, Yeh et al.
reported that the incidence of TB cases in aboriginal pop-
ulations in mountain areas decreased with distance from
foci in mountain areas. The Yeh study suggested that
recent or new infections, not reactivation, explained the
high incidence of TB in the general population of Taiwan
[2].
A Netherlands study estimated that the average patient
with untreated smear-positive pulmonary TB infects more
than ten patients annually during the natural course of the
disease [3]. However, identifying smear-positive TB cases
through control programs and treatment with effective
drug regimens can reduce the spread of infections. There-
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fore, timely and accurate diagnosis of TB and treatment
are vital. Delayed treatment can cause more infections per
case [4]. Delays can be categorized as patient delays or
health care system delays. Identifying when delays occur
and the factors related to types of delay can help tubercu-
losis control programs and medical providers improve
diagnosis and treatment efforts [5].
In Taiwan, an aggressive case monitoring system has been
in place since 1997 through the efforts of local public
health administrations in cooperation with the Taiwan
Centre for Disease Control (CDC). This monitoring sys-
tem requires medical personnel to report all suspected
and confirmed cases of TB to city or county local health
bureaus. Reliability of the reporting system is ensured by
two policies: the no-report-no-reimbursement policy and
the notification-fee policy [6]. One policy stipulates that a
medical facility failing to report a suspected case cannot
receive reimbursement by the Taiwan national health care
system. The second policy financially rewards the medical
facility for reporting suspected cases to local health
administrations. This monitoring system collects data as
of the dates the TB patient is diagnosed and treated. It pro-
vides a unique opportunity to study delayed treatment,
defined as the length of time between initial diagnosis
and initial treatment. Therefore, this study identified and
characterized TB cases with unusually long delays in treat-
ment to evaluate the effectiveness of TB control in Taiwan.
Methods
Data source
Data for all tuberculosis cases treated during 2002–2005
were obtained from the National Tuberculosis Registry
Campaign surveillance program. The TB surveillance pro-
gram was established by the Center for Disease Control
(CDC, Taiwan), Taiwan Department of Health, and began
collecting demographic, geographic, diagnostic and treat-
ment data for all diagnosed TB cases since 1997. This
study enrolled only TB patients with sputum smear- and/
or culture-positive TB. Treatment delays were measured as
the time from the date of definite diagnosis (i.e., confir-
mation by laboratory findings) to the date of initial treat-
ment for the disease. Any treatment initiated more than
seven days after diagnosis was considered delayed treat-
ment.
In Taiwan, physicians are required to immediately treat
patients with confirmed TB. Physicians who lack sufficient
expertise in treating TB must immediately refer the patient
to a pulmonologist. This referral process is usually accom-
plished within a week. Data for patients who experienced
treatment delays longer than 180 days were considered
incorrectly managed and excluded from analysis.
Statistical analysis
The annual distributions in days of delayed treatment
were analyzed. Differences between patients with TB
infection were tested by independent t test and Chi square
test. We employed Mantel-Haenszel Chi-square test for
linear trend to examine whether the confirmed TB cases
by laboratory diagnosis increased significantly over the
four-year period of analysis [7]. A P-value less than 0.05
was considered statistically significant. Distribution-fit-
ting and power function regression were performed to
examine whether the days of delayed treatment was
Power-law distributed, which was determined by the fol-
lowing formula:
P(k) ~ k-γ  (1)
where k represents the total days of treatment delay, and
P(k) indicates the number of TB cases receiving delayed
treatment. If the days of delayed treatment could be fitted
by a Power-law function with a high γ value (larger than
2), the number of TB cases would sharply decrease, indi-
cating that long delays are rare [8]. Most patients have
experienced short delay, but a significant number of
nodes have experienced a longer delayed treatment. The
LOTKA was used to fit the Power-law distribution [9]
Multivariate logistic regression was employed to model
the variables associated with long treatment delay. The
dependent variable is a binary variable. Patients with
treatment initiated more than seven days after diagnosis
was considered delayed treatment, coded as "1", other-
wise, coded as "0".
Results
Study population
The study analyzed 31,937 patients (4,432 in 2002, 7,146
in 2003, 9905 in 2004, and 10454 in 2005). The inci-
dence of cases confirmed by laboratory diagnosis
increased significantly over the four-year period of analy-
sis (Table 1). More males (22,294 males vs. 9,643
females) than females had pulmonary TB infections. The
mean age at diagnosis was 66.5 y/o for males vs. 61.7 y/o
for females (P < 0.05). Most patients with definite labora-
tory diagnosis were treated in hospitals (95.6%). The aver-
age days of delayed treatment (3.4 days) revealed no
gender difference (Table 2).
Distribution of treatment delays
The distribution of treatment delays was skewed. Mean
treatment delay was 6.1 days in 2002, 3.3 days in 2003,
3.1 days in 2004 and 3.0 days in 2005. Median and mode
of treatment delay was 0 during these years. In more than
95% of the patients, treatment commenced within 10
days after laboratory-confirmed diagnosis; only 0.5%–1%
had treatment delays longer than 100 days (Table 3).BMC Public Health 2008, 8:236 http://www.biomedcentral.com/1471-2458/8/236
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Patients with long treatment delay
Delayed treatment, defined as initial treatment seven or
more days after diagnosis, was noted in 2,813 patients
(8.8%). The total number of patients experiencing treat-
ment delays were 743 (16.8%) in 2002, 598 (8.4%) in
2003, 757 (7.6%) in 2004 and 715 (6.8%) in 2005. The
percentage of patients experiencing long delays decreased
significantly between 2002 and 2005. More males than
females experienced long treatment delays (M/F ratio:
2.52). In patients with long treatment delays, males were
older than females (67.6 years versus 63.2 years, respec-
tively, p < 0.05), and males tended to have longer delays
than females (28.8 days versus 26.4 days, respectively, p <
0.05) (Table 4).
The correlations between number of TB patients and days
of delayed treatment after diagnosis were similar for each
year (Fig. 1 to Fig. 4). The days of delayed treatment of TB
patients exhibited a Power-law distribution with a 95%
statistical significance, indicating that most patients were
treated immediately after diagnosis. Conversely, the abso-
lute values of γ in power-functions ranged from 2.12 to
2.35 with R-square = 0.90 (Fig. 1 to Fig. 4). This finding
suggests that a small number of patients experienced treat-
ment delays for a significant number of days.
Multivariate logistic regression results showed that gen-
der, type of treatment facilities, and year were significantly
associated with being long treatment delay. As compared
to women, men were 1.23 times more likely to be in long
treatment delay. Patients treated in hospitals were also
1.28 times more likely to be in long treatment delay, com-
pared to patients treated in clinics. Yearly difference was
also significant. The prevalence of long treatment delay in
2003 was 50% less than that in 2002 (the baseline), and
the prevalence of long treatment delay in 2004 and 2005
were 57% and 61% respectively less than that in 2002 (as
shown in Table 5).
Discussion
Delayed diagnosis and treatment of active tuberculosis
can be categorized as patient delay or health care system
delay. In the health care system, most delays are caused by
the diagnosing facility. Such delays can be further catego-
rized as delayed diagnosis or delayed treatment [10].
Regardless of cause, delayed diagnosis and treatment can
be catastrophic to those exposed to infected patients [11],
particularly medical personnel [12]. For example, the
large 2003 TB outbreak involving sixty healthcare workers
in a Taipei hospital was attributed to delayed diagnosis
and treatment [13].
Minimizing delays in diagnosis or treatment can substan-
tially improve TB prevention. Previous studies measured
patient and health care system delay [4,14-16] whereas
the current study focused on treatment delays after defi-
nite diagnosis in a health care system. The intent was to
focus on the severity of delays occurring. In Taiwan, the
Table 1: The incidence of TB patients with definite laboratory diagnosis in Taiwan during 2002–2005
TB cases with definite laboratory diagnosis Total Population Incidence of TB cases with definite laboratory diagnosis (/100,000 
population)
2002 4432 22520,776 19.7
2003 7145 22604,550 31.6
2004 9905 22689,122 43.7
2005 10454 22770,383 45.9
The incidence of cases with definite diagnosis increased significantly during these years. Mantel-Haenszel Chi-square for linear trend p < 0.001.
Table 2: Characteristics of TB patients with definite laboratory diagnosis in Taiwan during 2002–2005
Years 2002 2003 2004 2005 Total
Patients (n) 4432 7146 9905 10454 31937
Sex (M/F ratio) 2.32 2.38 2.3 2.27 2.31
Age* 66.3 ± 19.1 65.1 ± 18.7 65.5 ± 19.4 64.7 ± 19.2 65.2 ± 19.2
Male 67.9 ± 18.0 66.7 ± 18.0 66.4 ± 17.8 65.9 ± 18.1 66.5 ± 18
Female 62.5 ± 21.6 61.8 ± 21.8 62.4 ± 22.0 60.8 ± 20.8 61.7 ± 21.3
Patients with known treatment facilities 3430 (77.4%) 5505 (77.0%) 7742 (78.2%) 8305 (79.4%) 24982 (78.2%)
Hospital 3256 (94.5%) 5235 (95.1%) 7406 (95.7%) 7984 (96.1%) 23881 (95.6%)
Primary-care clinic 174 (5.1%) 270 (4.9%) 336 (4.3%) 321 (3.9%) 1101 (4.4%)
Delay (days) 6.1 ± 17.3 3.3 ± 12.1 3.1 ± 11.4 3.0 ± 11.1 3.4 ± 12.3
Male 6.2 ± 17.6 3.4 ± 12.2 3.2 ± 11.2 3.2 ± 11.0 3.5 ± 12.1
Female 4.9 ± 13.9 3.0 ± 9.8 3.0 ± 10.4 2.8 ± 11.0 3.2 ± 11.2
Data are n, means ± SD, or n (%). Number (n) of patients is given when the variable concerned is not measured in all patients.
* Chi-square tests P < 0.05.BMC Public Health 2008, 8:236 http://www.biomedcentral.com/1471-2458/8/236
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incidence of laboratory-confirmed diagnoses increased
gradually during these years. However, the incidence of TB
remained relatively stable. The increased incidence of def-
inite diagnosis may be attributable to improved accuracy
of diagnosis by healthcare facilities.
Among these patients, most cases of TB infection in Tai-
wan were males, which is consistent with previous stud-
ies. This gender difference may partly reflect
epidemiological differences, including differences in
exposure, infection risk, progression from infection to dis-
ease, socio-economic status, cultural factors and quality of
health care received [1,17-22].
However, although a gender difference in incidence was
noted, no gender difference was noted in number of days
of delay after definite diagnosis. Taiwan National Health
Insurance was implemented in 1995 to provide universal
health coverage. The national health insurance program
provides accessibility to health care at reasonable cost
[23]. This might have increased utilization of medical care
by both genders. Additionally, Taiwan also implemented
a no-report-no-reimbursement policy in 1997 which
penalizes medical facilities for not reporting possible TB
cases by denying reimbursement. Together, these meas-
ures may have helped improve the surveillance, diagnosis
and time to treatment of TB in the overall population.
However, this study revealed that more men than women
experienced long delays in treatment. A study in Yemen
demonstrated that women were more likely than men to
complete tuberculosis treatment [24], which suggests that
women have shorter treatment delays than males and
tend to receive treatment immediately after diagnosis.
Table 3: Distribution of the treatment delay for TB patients with definite laboratory diagnosis in Taiwan during 2002–2005
2002 2003 2004 2005
Delay (Day) N % N % N % N %
0 2 4 4 95 5 . 3 3 9 9 35 5 . 9 5 3 3 15 3 . 85 7 0 35 4 . 6
1~10 1402 31.6 2720 38.1 4026 40.6 4215 40.3
11~20 279 6.3 201 2.8 270 2.7 250 2.4
21~30 114 2.6 77 1.1 99 1.0 106 1.0
31~40 46 1.0 52 0.7 49 0.5 47 0.4
41~50 31 0.7 20 0.3 30 0.3 31 0.3
51~60 21 0.5 21 0.3 18 0.2 19 0.2
61~70 21 0.5 10 0.1 24 0.2 14 0.1
71~80 18 0.4 9 0.1 13 0.1 9 0.1
81~90 11 0.2 7 0.1 5 0.1 10 0.1
91~100 8 0.2 12 0.2 8 0.1 6 0.1
101~180 32 0.7 24 0.2 32 0.4 44 0.3
Total 4432 100.0 7146 100.0 9905 100.0 10454 100.0
Mean of Treatment delay 6.1 days 3.3 days 3.1 days 3.0 days
Median/Mode of treatment delay 0.0 days 0.0 days 0.0 days 0.0 days
Table 4: Characteristics of TB patients with long treatment delay in Taiwan during 2002–2005
Year 2002 2003 2004 2005 Total
Patients (n, %) 743 (16.8%) 598 (8.4%) 757 (7.6%) 715 (6.8%) 2813 (8.8%)
Sex (M/F ratio) 2.52 2.58 2.41 2.58 2.52
Age* 68.1 ± 18.4 67.5 ± 18.1 66.3 ± 18.6 64.1 ± 19.1 66.2 ± 18.4
Male 69.3 ± 17.2 68.3 ± 17.3 67.7 ± 16.9 65.2 ± 18.9 67.6 ± 17.3
Female 63.7 ± 20.1 65.3 ± 21.2 62.5 ± 21.3 61.6 ± 20.0 63.2 ± 20.5
Delay (days)** 29.2 ± 31.5 27.3 ± 30.4 27.1 ± 30.6 29.7 ± 32.1 28.0 ± 31.1
Male 30.9 ± 32.5 28.1 ± 31.1 27.6 ± 30.7 28.4 ± 31.3 28.8 ± 31.3
Female 24.6 ± 27.2 25.1 ± 25.4 25.9 ± 29.4 29.7 ± 33.8 26.4 ± 29.2
Patients with known treatment facilities 568 (76.4%) 429 (71.7%) 589 (77.8%) 518 (72.4%) 2104 (74.8%)
Hospital 542 (95.4%) 411 (95.8%) 565 (95.9%) 505 (97.5%) 2023 (96.2%)
Primary-care clinic 26 (4.6%) 18 (4.2%) 24 (4.1%) 13 (2.5%) 81 (3.8%)
Data are n, means ± SD, or n (%). Number (n) of patients is given when the variable concerned is not measured in all patients.
* Chi-square test, P < 0.05.
** t-test, P < 0.05.BMC Public Health 2008, 8:236 http://www.biomedcentral.com/1471-2458/8/236
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However, a Bangladesh study showed that women experi-
ence longer total delay, total diagnostic delay, patient
delay and treatment delay (males1.9 days, females 2.0
days) [25]. These inconsistencies highlight the impact of
different communities and cultures on gender differences
in tuberculosis treatment delays. Hence, a better under-
standing of the people and communities affected by
tuberculosis is needed to provide consistent and high
quality care [26].
Recent research indicates that many natural and social-
economic phenomena, such as income, disease-related
death and earthquake magnitude, follow a Power-law dis-
tribution rather than a bell-curve distribution. This
implies that small occurrences are common, and large
instances are rare but possibly devastating [27,28]. Our
study also revealed a Power-law distribution in TB treat-
ment, suggesting that while most TB cases are controlled
by public health authorities, the few patients who experi-
ence long delays in treatment can cause serious transmis-
sion. As can be seen in Fig. 1 to Fig. 2, the tail of the power-
law distribution has a much slower decay than other prob-
ability distributions, such as the Poisson distribution. The
probability that an extreme number will occur from a ran-
dom sample cannot be neglected if we are dealing with
power-law phenomena. It is worth noting that a Power-
law distribution in TB treatment, suggesting that while
most TB cases are controlled by public health authorities,
the few patients who experience long delays in treatment
can cause serious risk for transmission [29,30]. As Pastor-
Satorras and Vespignani [29] has revealed, in a power-law
distribution, epidemics can reproduce with a considerably
lower number of infected persons at each point in time,
Number of TB patients and days of treatment delay (2002) Figure 1
Number of TB patients and days of treatment delay 
(2002). Power-law distribution test, P < 0.001.
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than other probability distributions. Therefore, epidemics
in a power-law distribution will not exhibit a threshold. It
brings serious concerns for public health researchers
working in the field of tuberculosis control.
Additionally, based on the data in this study, long delays
in treatment usually occurred in hospitals (range: 94.5%
~ 96.1%) rather than in primary-care clinics. The likely
explanation is that not all physicians are familiar with
treatment of TB, especially in hospitals with many special-
ists. Chung et al. reported that physicians who are not pul-
monologists are less effective in treating TB [31]. We
speculate that if the attending physician cannot explain
the disease as convincingly as a pulmonologist, the
patient may choose to visit another doctor for a second
opinion or simply leave under the impression that the
doctor is uncertain or is reluctant to disclose the TB find-
ings because of the social stigma attached to the disease.
To minimize treatment delays and disease transmission,
the protocols for controlling TB at the hospital level must
be strengthened. For example, nurses responsible for hos-
pital TB control should be informed immediately after a
laboratory diagnosis is confirmed. The nurse can contact
the patient, inform primary doctor and arrange an imme-
diate visit to a pulmonologist.
Nevertheless, this study bears the following limitations.
First, the data analysis did not differentiate newly detected
cases from relapses. Second, global surveillance of drug
resistance has shown that a substantial proportion of
tuberculosis patients are infected with drug resistant
Mycobacterium tuberculosis strains [32]. Unfortunately,
the possibility of multiple-drug resistant TB (MDR-TB)
cannot be considered due to the lack of information in the
data set. However, based on the report from Chest hospi-
tal in Taiwan, multidrug resistance occurred in 42.2% of
retreated TB patients, and 1.8% of multidrug resistant iso-
lates were found in new TB patients from January 2002 to
June 2004 [33]. A recent report in May 2008 revealed that,
among 215 patients with MDR-TB, 42.8% (92/215) were
fluoroquinolone-resistant [34]. Fluoroquinolones are
widely used for the treatment of bacterial respiratory
infections in Taiwan. This treatment regimen of using
fluoroquinolone before definite diagnosis of pulmonary
TB might cause temporary symptom relief of the patient,
and might eventually cause treatment delay and drug
resistance [34]. Further studies are needed to examine the
extent of fluoroquinolone-resistance in patients with long
treatment delays.
Conclusion
This study found that TB control is generally acceptable in
Taiwan; however, delayed treatment increases the risk of
transmission. Improving the protocol for managing con-
firmed TB cases can minimize disease transmission.
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